Owner Arena Pharmaceuticals, Inc.

Inventors Dosa, Peter I.; Strah-Pleynet, Sonja; Jayakumar, Honnappa; Xu, Jingdong; Chapman, Dennis; Teegarden, Bradley; Decaire, Marc; Feichtinger, Konrad; Tran, Thuy-Anh

Agent FB Rice

Pub. Number AU-A-2007254244

PCT Pub. Number WO2007/136680

Priority 60/801,699 18.05.06 US

Filing date 17 May 2007

Wipo publication date 29 November 2007

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/42 (2006.01) - Oxazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/454 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 231/16 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 411/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms